Published on
Jul 25, 2025
Judge Rules Mylan Did Not Infringe Novo Nordisk Patent In Wegovy Generic Case
The Novo Nordisk A/S NVO attempt to block Mylan Pharmaceuticals from launching a generic version of its weight-loss drug Wegovy hit a major obstacle as the court ruled in Mylan's favor on key infringement claims related to U.S. Patent No. 9,764,003 …
Source:
Benzinga
-
Neutral
